Neuroregenerative potential of intravenous G-CSF and autologous peripheral blood stem cells in children with cerebral palsy: a randomized, double-blind, cross-over study

Table 2 Number of patients for functional improvement by parental assessment according to randomization (before vs after) and time of mPBMC infusion (T1 vs T7)

	Before randomization	After randomization			T1	T7	p*
	Before randomization	Placebo	mPBMC	p ⁺	T1	T7	p*
Cognitive function	19	31	23	0.09	8	11	0.59
Motor function	3	0	2	0.15	0	0	–
Cognitive + motor function	5	14	16	0.65	13	14	0.83
No interval change	20	2	6	0.13	1	0	0.28

mPBMC mobilized peripheral blood mononuclear cell; T1 and T7 refer to a group who received mPBMC at 1 and 7 months of study, respectively
⁺ p indicates statistical significances of items between placebo and mPBMC groups
*p indicates statistical significances of items between before T1 and T7 groups

ISSN: 1479-5876